International Corp/Ma Doubl... Net Worth

The estimated Net Worth of International Corp/Ma Doubl... is at least $1.91 Bilhão dollars as of 14 May 2021. International Doubl owns over 448,942 units of Syneos Health Inc stock worth over $271,095,877 and over the last 4 years International sold SYNH stock worth over $1,639,638,010.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

International Doubl SYNH stock SEC Form 4 insiders trading

International has made over 6 trades of the Syneos Health Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently International sold 6,307,489 units of SYNH stock worth $512,168,107 on 7 June 2021.

The largest trade International's ever made was selling 6,307,489 units of Syneos Health Inc stock on 7 June 2021 worth over $512,168,107. On average, International trades about 3,735,553 units every 44 days since 2020. As of 14 May 2021 International still owns at least 6,307,489 units of Syneos Health Inc stock.

You can see the complete history of International Doubl stock trades at the bottom of the page.

Insiders trading at Syneos Health Inc

Over the last 7 years, insiders at Syneos Health Inc have traded over $16,280,601,287 worth of Syneos Health Inc stock and bought 17,946 units worth $873,496 . The most active insiders traders include Todd M Abbrecht, John L. Maldonado, eTom Allen. On average, Syneos Health Inc executives and independent directors trade stock every 14 days with the average trade being worth of $83,067,962. The most recent stock trade was executed by Michael Lee Brooks on 28 July 2022, trading 1,502 units of SYNH stock currently worth $117,156.

What does Syneos Health Inc do?

inc research/inventiv health has become syneos health, the only fully integrated end-to-end clinical and commercial solution organization. we are purpose-built for biopharmaceutical acceleration, creating better, smarter, faster ways to help clients navigate an increasingly complex marketplace. our new business addresses today’s market realities through clinical and commercial sharing expertise and data and insights to meet the needs of emerging and large global biopharmaceutical companies.

Complete history of International Doubl stock trades at Syneos Health Inc

Syneos Health Inc executives and stock owners

Syneos Health Inc executives and other stock owners filed with the SEC include:

• Alistair Macdonald,
  Chief Executive Officer, Director
• Jason Meggs,
  Chief Financial Officer
• Paul Colvin,
  President - Clinical Solutions
• Michelle Keefe,
  President - Commercial Solutions
• Jonathan Olefson,
  General Counsel, Corporate Secretary
• Alistair Macdonald,
  CEO & Director
• Jason M. Meggs,
  Chief Financial Officer
• Paul D. Colvin,
  Chief Bus. Officer
• Michelle Keefe,
  Pres of Commercial Solutions
• Jonathan Olefson,
  Gen. Counsel & Corp. Sec.
• John Dineen,
  Independent Chairman of the Board
• William Klitgaard,
  Independent Director
• Kenneth Meyers,
  Independent Director
• Linda Harty,
  Independent Director
• Matthew Monaghan,
  Independent Director
• Joshua Nelson,
  Independent Director
• Todd Abbrecht,
  Independent Director
• Bernadette Connaughton,
  Independent Director
• Thomas Allen,
  Independent Director
• John Maldonado,
  Independent Director
• Ronnie Speight,
  Senior Vice President, Investor Relations
• Robert Parks,
  Executive Vice President, Chief Accounting Officer
• Lisa van Capelle,
  Chief Human Resource Officer
• Dr. Judith Ng-Cashin M.D.,
  Chief Scientific Officer
• Kristen Spensieri,
  Global Head of Corp. Communications & Marketing
• Larry A. Pickett Jr.,
  Chief Information & Digital Officer
• Dr. Judith Ng-Cashin,
  Chief Scientific Officer
• Donna Hildebrand Kralowetz,
  Sr. VP of Fin. & Principal Accounting Officer
• H. Lee Advisors, Llcthl Fun...,
  
• International Corp/Maap Gpe...,
  
• International Corp/Ma Doubl...,
  
• Tom Allen,
  
• International Corp/Ma Adven...,
  
• International Corp/Ma Adven...,
  
• International Corp/Ma Adven...,
  
• International Corp/Ma Adven...,
  
• International Corp/Ma Adven...,
  
• Christopher L Gaenzle,
  CAO, GC & Sec
• Michael Adam Bell,
  Director
• Joshua M Nelson,
  
• Todd M Abbrecht,
  
• H. Lee Advisors, Llcthl Hol...,
  
• H. Lee Advisors, Llc Thomas...,
  
• International Corp/Ma Adven...,
  
• H. Lee Advisors, Llc Thomas...,
  
• H. Lee Advisors, Llcthl Fun...,
  
• H. Lee Equity Fund Vi, L.P....,
  
• Christian Tucat,
  Chief Business Officer
• Michael Lee Brooks,
  Chief Operating Officer
• Barbara W. Bodem,
  Director
• Alfonso G Zulueta,
  Director
• Stanford Rudnick,
  See remarks
• International Corp/Ma Adven...,
  
• International Corp/Ma Adven...,
  
• International Corp/Ma Adven...,
  
• Michael J. Bonello,
  Chief Financial Officer
• Donna Hildebrand Kralowetz,
  EVP, Chief Accounting Officer
• International Corp/Ma Adven...,
  
• International Corp/Ma Adven...,
  
• International Corp/Ma Adven...,
  
• H. Lee Advisors, Llcthl Fun...,
  
• International Corp/Maap Gpe...,
  
• International Corp/Maap Gpe...,
  
• David S. Wilkes,
  Director